Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Moritz, Steffen
Andresen, Burghard
Naber, Dieter
Krausz, Michael
and
Probsthein, Ellen
1999.
Neuropsychological Correlates of Schizotypal Disorganisation.
Cognitive Neuropsychiatry,
Vol. 4,
Issue. 4,
p.
343.
Moritz, Steffen
Heeren, Deike
Andresen, Burghard
and
Krausz, Michael
2001.
An analysis of the specificity and the syndromal correlates of verbal memory impairments in schizophrenia.
Psychiatry Research,
Vol. 101,
Issue. 1,
p.
23.
Moritz, S.
Andresen, B.
Jacobsen, D.
Mersmann, K.
Wilke, U.
Lambert, M.
Naber, D.
and
Krausz, M.
2001.
Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics.
European Psychiatry,
Vol. 16,
Issue. 6,
p.
354.
Moritz, S.
Woodward, T. S.
Krausz, M.
and
Naber, D.
2002.
Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication.
International Clinical Psychopharmacology,
Vol. 17,
Issue. 1,
p.
41.
Moritz, S.
Persist, Arbeitsgruppe
Krausz, M.
and
Naber, D.
2003.
Universitätskolloquien zur Schizophrenie.
p.
257.
Lambert, Martin
Conus, Philippe
Lambert, Tim
and
McGorry, Pat D
2003.
Pharmacotherapy of first-episode psychosis.
Expert Opinion on Pharmacotherapy,
Vol. 4,
Issue. 5,
p.
717.
Carvajal, Alfonso
and
Martín Arias, Luis H.
2004.
Vol. 27,
Issue. ,
p.
49.
2006.
Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions.
p.
2438.
Timdahl, Kristina
Carlsson, Anders
and
Stening, Göran
2007.
An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
Human Psychopharmacology: Clinical and Experimental,
Vol. 22,
Issue. 5,
p.
315.
Narasimhan, Meera
Un Pae, Chi
Masand, Natasha
and
Masand, Prakash
2007.
Partial compliance with antipsychotics and its impact on patient outcomes.
International Journal of Psychiatry in Clinical Practice,
Vol. 11,
Issue. 2,
p.
102.
Janno, Sven
Holi, Matti M
Tuisku, Katinka
and
Wahlbeck, Kristian
2008.
Neuroleptic-induced movement disorders in a naturalistic schizophrenia population: diagnostic value of actometric movement patterns.
BMC Neurology,
Vol. 8,
Issue. 1,
2009.
Meyler's Side Effects of Psychiatric Drugs.
p.
185.
Kim, Jong‐Hoon
and
Byun, Hee‐Jung
2009.
Non‐motor cognitive‐perceptual dysfunction associated with drug‐induced parkinsonism.
Human Psychopharmacology: Clinical and Experimental,
Vol. 24,
Issue. 2,
p.
129.
Potvin, Stéphane
Aubin, Ginette
and
Stip, Emmanuel
2015.
Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 265,
Issue. 2,
p.
147.
Bo, Qi-Jing
Li, Xian-Bin
Wang, Zhi-Min
Li, An-Ning
Ma, Xin
and
Wang, Chuan-Yue
2016.
Extrapyramidal Symptoms During Risperidone Maintenance Treatment in Schizophrenia.
Journal of Clinical Psychopharmacology,
Vol. 36,
Issue. 2,
p.
125.
2016.
Meyler's Side Effects of Drugs.
p.
53.
Chan, Chia-Hsiang
Chan, Hung-Yu
and
Chen, Yen-Ching
2018.
Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia.
International Clinical Psychopharmacology,
Vol. 33,
Issue. 3,
p.
155.
Monteleone, Palmiero
Cascino, Giammarco
Monteleone, Alessio Maria
Rocca, Paola
Rossi, Alessandro
Bertolino, Alessandro
Aguglia, Eugenio
Amore, Mario
Collantoni, Enrico
Corrivetti, Giulio
Cuomo, Alessandro
Bellomo, Antonello
D’Ambrosio, Enrico
Dell’Osso, Liliana
Frascarelli, Marianna
Giordano, Giulia Maria
Giuliani, Luigi
Marchesi, Carlo
Montemagni, Cristiana
Oldani, Lucio
Pinna, Federica
Pompili, Maurizio
Roncone, Rita
Rossi, Rodolfo
Siracusano, Alberto
Vita, Antonio
Zeppegno, Patrizia
Galderisi, Silvana
and
Maj, Mario
2021.
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life”.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 109,
Issue. ,
p.
110250.
Daderwal, Mukesh Chand
Sreeraj, Vanteemar S
Suhas, Satish
Rao, Naren P
and
Venkatasubramanian, Ganesan
2022.
Montreal Cognitive Assessment (MoCA) and Digit Symbol Substitution Test (DSST) as a screening tool for evaluation of cognitive deficits in schizophrenia.
Psychiatry Research,
Vol. 316,
Issue. ,
p.
114731.
Moura, Bernardo Melo
Madeira, Luís
Bakker, P. Roberto
van Harten, Peter
and
Marcelis, Machteld
2024.
The association between alterations in motor and cognitive dimensions of schizophrenia-spectrum disorders: A systematic review.
Schizophrenia Research,
Vol. 267,
Issue. ,
p.
398.
Comments
No Comments have been published for this article.